Cargando…

Selection of Microsatellite Markers for Bladder Cancer Diagnosis without the Need for Corresponding Blood

Microsatellite markers are used for loss-of-heterozygosity, allelic imbalance and clonality analyses in cancers. Usually, tumor DNA is compared to corresponding normal DNA. However, normal DNA is not always available and can display aberrant allele ratios due to copy number variations in the genome....

Descripción completa

Detalles Bibliográficos
Autores principales:	van Tilborg, Angela A. G., Kompier, Lucie C., Lurkin, Irene, Poort, Ricardo, El Bouazzaoui, Samira, van der Keur, Kirstin, Zuiverloon, Tahlita, Dyrskjot, Lars, Orntoft, Torben F., Roobol, Monique J., Zwarthoff, Ellen C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3425555/ https://www.ncbi.nlm.nih.gov/pubmed/22927958 http://dx.doi.org/10.1371/journal.pone.0043345

Ejemplares similares

In-depth investigation of the molecular pathogenesis of bladder cancer in a unique 26-year old patient with extensive multifocal disease: a case report
por: Zuiverloon, Tahlita CM, et al.
Publicado: (2010)

A SNaPshot assay for the rapid and simple detection of four common hotspot codon mutations in the PIK3CA gene
por: Hurst, Carolyn D, et al.
Publicado: (2009)

FGFR3, HRAS, KRAS, NRAS and PIK3CA Mutations in Bladder Cancer and Their Potential as Biomarkers for Surveillance and Therapy
por: Kompier, Lucie C., et al.
Publicado: (2010)

Two Multiplex Assays That Simultaneously Identify 22 Possible Mutation Sites in the KRAS, BRAF, NRAS and PIK3CA Genes
por: Lurkin, Irene, et al.
Publicado: (2010)

Analysis of molecular intra-patient variation and delineation of a prognostic 12-gene signature in non-muscle invasive bladder cancer; technology transfer from microarrays to PCR
por: Dyrskjøt, L, et al.
Publicado: (2012)

Role of Bladder Cancer Metabolic Reprogramming in the Effectiveness of Immunotherapy
por: Scholtes, Mathijs P., et al.
Publicado: (2021)

Systematic Review: Characteristics and Preclinical Uses of Bladder Cancer Cell Lines
por: Zuiverloon, Tahlita C.M., et al.
Publicado: (2018)

Improving Anti-PD-1/PD-L1 Therapy for Localized Bladder Cancer
por: de Jong, Florus C., et al.
Publicado: (2021)

Open versus minimal invasive radical cystectomy
por: van Diepen, Danielle C., et al.
Publicado: (2020)

Evidence for two candidate tumour suppressor loci on chromosome 9q in transitional cell carcinoma (TCC) of the bladder but no homozygous deletions in bladder tumour cell lines
por: Tilborg, A A G van, et al.
Publicado: (1999)

Biomarker-Oriented Therapy in Bladder and Renal Cancer
por: Scholtes, Mathijs P., et al.
Publicado: (2021)

Chromosomal imbalance in the progression of high-risk non-muscle invasive bladder cancer
por: Zieger, Karsten, et al.
Publicado: (2009)

Molecular Biomarkers of Response to PD-1/ PD-L1 Immune Checkpoint Blockade in Advanced Bladder Cancer(1)
por: Tu, Megan M., et al.
Publicado: (2019)

High expression of GEM and EDNRA is associated with metastasis and poor outcome in patients with advanced bladder cancer
por: Laurberg, Jens Reumert, et al.
Publicado: (2014)

Diagnosis of Bladder Cancer Recurrence Based on Urinary Levels of EOMES, HOXA9, POU4F2, TWIST1, VIM, and ZNF154 Hypermethylation
por: Reinert, Thomas, et al.
Publicado: (2012)

The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladder
por: van Doeveren, Thomas, et al.
Publicado: (2020)

Risk Prediction Scores for Recurrence and Progression of Non-Muscle Invasive Bladder Cancer: An International Validation in Primary Tumours
por: Vedder, Moniek M., et al.
Publicado: (2014)

Artificial Intelligence in Digital Pathology for Bladder Cancer: Hype or Hope? A Systematic Review
por: Khoraminia, Farbod, et al.
Publicado: (2023)

A reported 20-gene expression signature to predict lymph node-positive disease at radical cystectomy for muscle-invasive bladder cancer is clinically not applicable
por: van Kessel, Kim E. M., et al.
Publicado: (2017)

Sewage surveillance system using urological wastewater: Key to COVID-19 monitoring?
por: de Jong, Florus C., et al.
Publicado: (2023)

Bioinformatic identification of FGF, p38-MAPK, and calcium signalling pathways associated with carcinoma in situ in the urinary bladder
por: Herbsleb, Malene, et al.
Publicado: (2008)

Elevated Derived Neutrophil-to-Lymphocyte Ratio Corresponds With Poor Outcome in Patients Undergoing Pre-Operative Chemotherapy in Muscle-Invasive Bladder Cancer
por: van Kessel, Kim E.M., et al.
Publicado: (2016)

Increased cell motility and invasion upon knockdown of lipolysis stimulated lipoprotein receptor (LSR) in SW780 bladder cancer cells
por: Herbsleb, Malene, et al.
Publicado: (2008)

The Use of Molecular Analyses in Voided Urine for the Assessment of Patients with Hematuria
por: Beukers, Willemien, et al.
Publicado: (2013)

High frequency of tumor cells with nuclear Egr-1 protein expression in human bladder cancer is associated with disease progression
por: Egerod, Frederikke Lihme, et al.
Publicado: (2009)

High miR-449b expression in prostate cancer is associated with biochemical recurrence after radical prostatectomy
por: Mortensen, Martin Mørck, et al.
Publicado: (2014)

miRNAs associated with chemo-sensitivity in cell lines and in advanced bladder cancer
por: Nordentoft, Iver, et al.
Publicado: (2012)

Increased expression of transcription factor TFAP2α correlates with chemosensitivity in advanced bladder cancer
por: Nordentoft, Iver, et al.
Publicado: (2011)

Limited Funds for Bladder Cancer Research and What Can We Do About It
por: Boormans, Joost L., et al.
Publicado: (2016)

Gene expression signatures for colorectal cancer microsatellite status and HNPCC
por: Kruhøffer, M, et al.
Publicado: (2005)

Are microRNAs located in genomic regions associated with cancer?
por: Lamy, P, et al.
Publicado: (2006)

Comprehensive multiregional analysis of molecular heterogeneity in bladder cancer
por: Thomsen, Mathilde Borg Houlberg, et al.
Publicado: (2017)

Evaluation of two commercial global miRNA expression profiling platforms for detection of less abundant miRNAs
por: Jensen, Steffen G, et al.
Publicado: (2011)

Expression profiling of prostate cancer tissue delineates genes associated with recurrence after prostatectomy
por: Mortensen, Martin Mørck, et al.
Publicado: (2015)

Prediction and diagnosis of bladder cancer recurrence based on urinary content of hTERT, SENP1, PPP1CA, and MCM5 transcripts
por: Brems-Eskildsen, Anne Sofie, et al.
Publicado: (2010)

Novel diagnostic and prognostic classifiers for prostate cancer identified by genome-wide microRNA profiling
por: Kristensen, Helle, et al.
Publicado: (2016)

Correspondence
por: Berry, A., et al.
Publicado: (1846)

Detection of multiple mutations in urinary exfoliated cells from male bladder cancer patients at diagnosis and during follow-up
por: Critelli, Rossana, et al.
Publicado: (2016)

Gene expression profiling of noninvasive primary urothelial tumours using microarrays
por: Aaboe, M, et al.
Publicado: (2005)

Comparative analysis of discrete exosome fractions obtained by differential centrifugation
por: Jeppesen, Dennis K., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_kq9d9549mam4ohcsa3bmiufd57